BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 34539386)

  • 1. Risk Factors for Atorvastatin as a Monotherapy for Chronic Subdural Hematoma: A Retrospective Multifactor Analysis.
    Zhang X; Wang D; Tian Y; Wei H; Liu X; Xiang T; Fan Y; Gao C; Huang J; Sha Z; Quan W; Zhang J; Jiang R
    Front Aging Neurosci; 2021; 13():726592. PubMed ID: 34539386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of atorvastatin on resolution of chronic subdural hematoma: a prospective observational study [RETRACTED].
    Liu H; Liu Z; Liu Y; Kan S; Yang J; Liu H
    J Neurosurg; 2016 Jul; ():1-10. PubMed ID: 27471887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of atorvastatin on chronic subdural hematoma: a preliminary report from three medical centers.
    Wang D; Li T; Tian Y; Wang S; Jin C; Wei H; Quan W; Wang J; Chen J; Dong J; Jiang R; Zhang J
    J Neurol Sci; 2014 Jan; 336(1-2):237-42. PubMed ID: 24269089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients: A Randomized ClinicalTrial.
    Jiang R; Zhao S; Wang R; Feng H; Zhang J; Li X; Mao Y; Yuan X; Fei Z; Zhao Y; Yu X; Poon WS; Zhu X; Liu N; Kang D; Sun T; Jiao B; Liu X; Yu R; Zhang J; Gao G; Hao J; Su N; Yin G; Zhu X; Lu Y; Wei J; Hu J; Hu R; Li J; Wang D; Wei H; Tian Y; Lei P; Dong JF; Zhang J
    JAMA Neurol; 2018 Nov; 75(11):1338-1346. PubMed ID: 30073290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ATorvastatin On Chronic subdural Hematoma (ATOCH): a study protocol for a randomized controlled trial.
    Jiang R; Wang D; Poon WS; Lu YC; Li XG; Zhao SG; Wang RZ; You C; Yuan XR; Zhang JM; Feng H; Fei Z; Yu XG; Zhao YL; Hu J; Kang DZ; Yu RT; Gao GD; Zhu XD; Sun T; Hao JH; Liu XZ; Su N; Yue SY; Zhang JN
    Trials; 2015 Nov; 16():528. PubMed ID: 26581842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Recurrence of Chronic Subdural Hematoma: A Single Center Experience.
    Liu LX; Cao XD; Ren YM; Zhou LX; Yang CH
    World Neurosurg; 2019 Dec; 132():e506-e513. PubMed ID: 31450003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factor Analysis of the Conservative Treatment in Chronic Subdural Hematomas: A Substudy of the ATOCH Trial.
    Wang D; Tian Y; Wei H; Gao C; Fan Y; Yang G; Quan W; Huang J; Yue S; Zhang J; Jiang R
    Adv Ther; 2022 Apr; 39(4):1630-1641. PubMed ID: 35133631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of atorvastatin for chronic subdural haematoma: a retrospective cohort comparison study
    Chan DY; Chan DT; Sun TF; Ng SC; Wong GK; Poon WS
    Br J Neurosurg; 2017 Feb; 31(1):72-77. PubMed ID: 27881024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin Concentration May Affect the Effect of Atorvastin on Chronic Subdural Hematoma After Burr-Hole Drainage at High Altitude.
    Wei L; Lin C; Zhong M; Zhang J; Zhu G
    Front Neurosci; 2020; 14():503. PubMed ID: 32595442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of atorvastatin on recurrence of chronic subdural hematoma after novel YL-1 puncture needle surgery.
    Wang D; Wang H; Xu M; Chen P; Yu B; Wen J; Zhang H; Zeng W; He S; Wang C
    Clin Neurol Neurosurg; 2021 Mar; 202():106548. PubMed ID: 33609954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing wait-and-watch management in mild primary chronic subdural hematoma: a retrospective case-control study.
    Zhang X; Sha Z; Gao C; Yuan J; He L; Huang J; Jiang R
    Acta Neurol Belg; 2023 Dec; 123(6):2277-2286. PubMed ID: 37269419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of hospital mortality in chronic subdural hematoma: A retrospective analysis of 1117 patients, a single institute experience.
    Wang S; Ma Y; Zhao X; Yang C; Gu J; Weng W; Hui J; Mao Q; Gao G; Feng J
    J Clin Neurosci; 2019 Sep; 67():46-51. PubMed ID: 31213382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of computed tomography texture analysis in identifying chronic subdural hematoma patients with a good response to polytherapy.
    Sha Z; Wu D; Dong S; Liu T; Wu C; Lv C; Liu M; Jiang W; Yuan J; Nie M; Gao C; Liu F; Zhang X; Jiang R
    Sci Rep; 2024 Feb; 14(1):3559. PubMed ID: 38347043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative subdural hygroma and chronic subdural hematoma after unruptured aneurysm surgery: age, sex, and aneurysm location as independent risk factors.
    Park J; Cho JH; Goh DH; Kang DH; Shin IH; Hamm IS
    J Neurosurg; 2016 Feb; 124(2):310-7. PubMed ID: 26275003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and validation of a CT-based prediction model for the good dissolution of mild chronic subdural hematoma with atorvastatin treatment.
    Zhang X; Sha Z; Feng D; Wu C; Tian Y; Wang D; Wang J; Jiang R
    Neuroradiology; 2024 Jul; 66(7):1113-1122. PubMed ID: 38587561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal Cistern Effacement and Pseudo-Subarachnoid Hemorrhage on Computed Tomography Images of Chronic Subdural Hematoma.
    Atsumi H; Sorimachi T; Nonaka Y; Matsumae M
    World Neurosurg; 2019 Dec; 132():e109-e115. PubMed ID: 31518737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Trauma Catheter and Mushroom Tip Catheter in Evacuation of Chronic Subdural Hematoma and Complications of Drain Placement.
    Toor H; Bowen I; Zampella B; Majeed G; Elia C; Berry JA; Lawandy S; Menoni R; Miulli DE
    Cureus; 2019 Jul; 11(7):e5123. PubMed ID: 31523554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma.
    Liu H; Luo Z; Liu Z; Yang J; Kan S
    Front Neurosci; 2016; 10():303. PubMed ID: 27445673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Postoperative Morbidity After Chronic Subdural Hematoma: Predictive Usefulness of the Physiological and Operative Severity Score for Enumeration of Mortality and Morbidity, American College of Surgeons National Surgical Quality Improvement Program, and American Society of Anesthesiologists Grade in a Prospective Cohort.
    Thomas PAW; Mitchell PS; Marshman LAG
    World Neurosurg; 2019 Apr; 124():e489-e497. PubMed ID: 30610985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-surgical patient characteristics best predict outcome after 6 months in patients surgically treated for chronic subdural haematoma.
    Melander N; Sönnerqvist C; Olivecrona M
    J Clin Neurosci; 2023 Aug; 114():151-157. PubMed ID: 37429160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.